Valbiotis SA debuts on an e-commerce platform dedicated to cholesterol management

Valbiotis S.A. (FR:ALVAL) has released an update.

Valbiotis SA, a French laboratory specializing in dietary supplements for metabolic disorders, has launched an e-commerce platform to commercialize Valbiotis®PRO Cholesterol, an innovative product intended for the treatment of mild and moderate hypercholesterolemia. The supplement based on the natural active substance Lipidrive® is now available online and in pharmacies, and the company has also released an exclusive range of natural dietary supplements Valbiotis®PLUS. The premiere is supported by a digital marketing strategy and a dedicated team of Medical Promotion Representatives.

For more information on FR:ALVAL stock, check out TipRanks Stock analysis page.